Our findings were validated using another CD4 + T-cell RNA-sequencing dataset [27] and support previous results from multiple sources showing that lipid metabolism is dysregulated in patients with MS or EAE [35, 43, 44, 52, 59]. This evidence concerns the gene CD4 and myeloid sarcoma.